| Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial J Rodon, JC Soria, R Berger, WH Miller, E Rubin, A Kugel, A Tsimberidou, ... Nature medicine 25 (5), 751-758, 2019 | 437 | 2019 |
| Angiogenesis and lung cancer: prognostic and therapeutic implications RS Herbst, A Onn, A Sandler Journal of Clinical Oncology 23 (14), 3243-3256, 2005 | 330 | 2005 |
| Weight loss and improvement of obesity-related illness in 500 US patients following laparoscopic adjustable gastric banding procedure H Spivak, MF Hewitt, A Onn, EE Half The American journal of surgery 189 (1), 27-32, 2005 | 220 | 2005 |
| Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status S Baser, VR Shannon, GA Eapen, CA Jimenez, A Onn, E Lin, RC Morice Chest 130 (6), 1784-1790, 2006 | 203 | 2006 |
| BRAF mutant lung cancer: programmed death ligand 1 expression, tumor mutational burden, microsatellite instability status, and response to immune check-point inhibitors E Dudnik, N Peled, H Nechushtan, M Wollner, A Onn, A Agbarya, ... Journal of Thoracic Oncology 13 (8), 1128-1137, 2018 | 197 | 2018 |
| Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice A Onn, T Isobe, S Itasaka, W Wu, MS O’Reilly, W Ki Hong, IJ Fidler, ... Clinical cancer research 9 (15), 5532-5539, 2003 | 194 | 2003 |
| Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell … A Onn, AM Correa, M Gilcrease, T Isobe, E Massarelli, CD Bucana, ... Clinical Cancer Research 10 (1), 136-143, 2004 | 186 | 2004 |
| Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis RS Herbst, JV Heymach, MS O’Reilly, A Onn, AJ Ryan Expert opinion on investigational drugs 16 (2), 239-249, 2007 | 184 | 2007 |
| Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo DC Lev, A Onn, VO Melinkova, C Miller, V Stone, M Ruiz, EC McGary, ... Journal of Clinical Oncology 22 (11), 2092-2100, 2004 | 176 | 2004 |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ... Annals of Oncology 27 (3), 417-423, 2016 | 161 | 2016 |
| Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo M Giladi, U Weinberg, RS Schneiderman, Y Porat, M Munster, T Voloshin, ... Seminars in oncology 41, S35-S41, 2014 | 125 | 2014 |
| Tumor cavitation in stage I non–small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome A Onn, DH Choe, RS Herbst, AM Correa, RF Munden, MT Truong, ... Radiology 237 (1), 342-347, 2005 | 123 | 2005 |
| Exhaled breath analysis for monitoring response to treatment in advanced lung cancer I Nardi-Agmon, M Abud-Hawa, O Liran, N Gai-Mor, M Ilouze, A Onn, J Bar, ... Journal of Thoracic Oncology 11 (6), 827-837, 2016 | 118 | 2016 |
| Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice S Itasaka, R Komaki, RS Herbst, K Shibuya, T Shintani, NR Hunter, A Onn, ... International Journal of Radiation Oncology* Biology* Physics 67 (3), 870-878, 2007 | 107 | 2007 |
| Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade W Wu, A Onn, T Isobe, S Itasaka, RR Langley, T Shitani, K Shibuya, ... Molecular cancer therapeutics 6 (2), 471-483, 2007 | 97 | 2007 |
| Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice DC Lev, SJ Kim, A Onn, V Stone, DH Nam, S Yazici, IJ Fidler, JE Price Clinical cancer research 11 (1), 306-314, 2005 | 97 | 2005 |
| Screening for lung cancer: time for large-scale screening by chest computed tomography D Shlomi, R Ben-Avi, GR Balmor, A Onn, N Peled European Respiratory Journal 44 (1), 217-238, 2014 | 93 | 2014 |
| Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial J Rodon, JC Soria, R Berger, G Batist, A Tsimberidou, C Bresson, JJ Lee, ... Annals of Oncology 26 (8), 1791-1798, 2015 | 91 | 2015 |
| Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study J Bar, G Markel, T Gottfried, R Percik, R Leibowitz-Amit, R Berger, T Golan, ... European Journal of Cancer 120, 122-131, 2019 | 84 | 2019 |
| Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer EM Marom, CH Martinez, MT Truong, X Lei, BS Sabloff, RF Munden, ... Journal of Thoracic Oncology 3 (4), 351-357, 2008 | 84 | 2008 |
